Position in STE
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$21,031,099
-$1,054,923 QoQ
Shares Held
99,877
-0.0% QoQ
Ownership
0.102%
of shares outstanding
% of Portfolio
0.46%
of 13F equity value
Holder Rank
#98
of 822 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in STE Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026Bellevue Group AG holds $543,574,221 across 18 Medical Devices names. STE ranks #7 (3.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
947,115 | $85,941,215 | |
| 2 | SYK |
Stryker Corp
|
268,461 | $84,522,261 | |
| 3 | MDT |
Medtronic plc
|
994,233 | $77,778,847 | |
| 4 | EW |
Edwards Lifesciences Corp
|
739,234 | $66,871,107 | |
| 5 | DXCM |
Dexcom Inc
|
822,489 | $55,394,634 | |
| 6 | BSX |
Boston Scientific Corp
|
887,650 | $37,884,902 | |
| 7 | STE |
STERIS plc
This page
|
99,877 | $21,031,099 | |
| 8 | PODD |
Insulet Corp
|
127,498 | $19,411,570 |
All Filings in STE
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $21,031,099 | 99,877 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $22,086,022 | 99,878 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $25,784,251 | 101,705 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $29,225,633 | 118,112 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $26,397,055 | 109,887 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $24,905,888 | 109,887 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $22,588,371 | 109,887 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $22,139,536 | 91,282 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $20,040,050 | 91,282 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $16,509,431 | 73,434 | Shares | Defined | 2024-05-15 | |
| No filing history on record for this holder in this stock. | ||||||